Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Larimar Therapeutics (LRMR) Other Gross PP&E Adjustments (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with -$7.2 million as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Other Gross PP&E Adjustments fell 2373.1% year-over-year to -$7.2 million, compared with a TTM value of -$1.4 million through Dec 2019, up 59.55%, and an annual FY2018 reading of -$3.4 million, up 23.96% over the prior year.
  • Other Gross PP&E Adjustments was -$7.2 million for Q3 2019 at Larimar Therapeutics, up from -$7.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$267000.0 in Q3 2017 and bottomed at -$7.3 million in Q2 2019.
  • Average Other Gross PP&E Adjustments over 5 years is -$1.9 million, with a median of -$564000.0 recorded in 2018.
  • The sharpest move saw Other Gross PP&E Adjustments soared 46.52% in 2016, then tumbled 2373.1% in 2019.
  • Year by year, Other Gross PP&E Adjustments stood at -$1.8 million in 2015, then plummeted by 187.03% to -$5.0 million in 2016, then rose by 10.19% to -$4.5 million in 2017, then grew by 23.96% to -$3.4 million in 2018, then tumbled by 108.13% to -$7.2 million in 2019.
  • Business Quant data shows Other Gross PP&E Adjustments for LRMR at -$7.2 million in Q3 2019, -$7.3 million in Q2 2019, and -$1.4 million in Q1 2019.